Cervix CancerNCT06252012
The Effect of Cervical Cancer Awareness Education Based on Mobile Application
A study testing Mobile application in people with Cervix Cancer and Cancer Awareness, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
Trial summary
Cervical cancer is one of the most common cancer types affecting women in our country and in the world and causing morbidity. However, the availability of a vaccine for cervical cancer, preventable risk factors and early diagnosis tests offer a unique opportunity to reduce the rate of cervical cancer. Read more about this study
- Who is it for?
- Ages 35 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cervix Cancer, Cancer Awareness, Mobile Application
- What is being tested?
- Mobile application
- Type of treatment
- Vaccines, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Apr 2024to 27 May 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- She applied to Yıldırım Beyazıt Family Health Center and Zafertepe Family Health Center in Kütahya.
- No pregnancy or malignancy,
- No hearing and vision problems,
- Between the ages of 30-65,
- Having a smart phone,
- sexually active
- Can read and write Turkish,
- Have not had a pap-smear test in the last 5 years,
Who cannot join
- Pregnancy women Breastfeeding Have a history of cancer Have undergone hysterectomy operation Those who have undergone an operation for cervical cancer (cryosurgery, etc.)
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Kutahya Health Science University
Kütahya, Merkez, 43000
About this study
Official title: The Effect of Cervical Cancer Awareness Education Based on Mobile Application on Women's Attitudes and Behaviors Regarding Cervical Cancer Prevention and Early Diagnosis
Cervical cancer is one of the most common cancer types affecting women in our country and in the world and causing morbidity. However, the availability of a vaccine for cervical cancer, preventable risk factors and early diagnosis tests offer a unique opportunity to reduce the rate of cervical cancer. In this context, there are studies showing that the practices developed by policies differ and that the classical health approach is insufficient. The effectiveness of the trainings given may vary according to time, place, trainer and personal characteristics of the individual. At the same time, in order to improve the attitudes and behaviours of individuals in terms of prevention and early diagnosis of cervical cancer, awareness of individuals about cervical cancer should be increased. In this way, women will have a say about their own health and their conscious participation in health care services will be realised. Therefore, the aim of this project is to apply cervical cancer awareness training to women and to examine its effect on women's cervical cancer prevention and early diagnosis behaviours. Original value; The fact that there is no mobile application developed for cervical cancer in Turkey reveals the national value of the research. In addition, the mobile application has international unique value as it is the first mobile application structured to provide awareness on cervical cancer prevention and early diagnosis behaviours. The project method was planned for the development and implementation of the mobile application programme. The research design will be a randomised controlled study. The 120 women who meet the inclusion criteria and who apply to more than one family health centre will be randomly assigned to the intervention and control groups. The effect of the mobile application programme on women's attitudes and behaviours towards cervical cancer prevention and early diagnosis will be evaluated at the 6th and 12th weeks. In the evaluation of the data, t-test for independent groups, anova and chi-square tests will be used to measure the effect of the intervention. Widespread effect; In this way, it is planned to reduce the time spent by professionals for care-related activities, to strengthen time management, to provide advantages and improvements in the performance of nurses in patient care management by using technological resources in the health care provided.
Read the detailed description
Cervical cancer is one of the most common cancer types affecting women in our country and in the world and causing morbidity. However, the availability of a vaccine for cervical cancer, preventable risk factors and early diagnosis tests offer a unique opportunity to reduce the rate of cervical cancer. The World Health Organization launched the "global strategy to accelerate the elimination of cervical cancer as a public health problem" programme in 2020 to eliminate cervical cancer by 2030. In this context, there are studies showing that the practices developed by policies differ and that the classical health approach is insufficient. The effectiveness of the trainings given may vary according to time, place, trainer and personal characteristics of the individual. At the same time, in order to improve the attitudes and behaviours of individuals in terms of prevention and early diagnosis of cervical cancer, awareness of individuals about cervical cancer should be increased. In this way, women will have a say about their own health and their conscious participation in health care services will be realised. Therefore, the aim of this project is to apply cervical cancer awareness training to women and to examine its effect on women's cervical cancer prevention and early diagnosis behaviours. Original value; the fact that there is no mobile application developed for cervical cancer in our country reveals the national value of the research. In addition, the mobile application has an international unique value as it is the first mobile application structured to provide awareness about cervical cancer prevention and early diagnosis behaviours. It is thought that the mobile application programme to be developed has a unique content that provides knowledge and skills to increase the health culture and participation in health decisions thanks to its educational content such as cervical cancer risk factors, prevention methods, diagnostic tests, test results, treatment methods. In addition, it is the first mobile application developed in the national/international field regarding cervical cancer prevention and early diagnosis attitudes and behaviours in line with the deficiencies identified in the literature. The project method was planned for the development and implementation of the mobile application programme. The research design will be a randomised controlled study. A total of 120 women who meet the inclusion criteria and apply to more than one family health centre will be randomly assigned to the intervention (women who use the mobile application programme) and control groups (women who receive the standard education booklet). The mobile application programme includes a total of 12 interfaces for cervical cancer prevention and early diagnosis of cervical cancer. The content of the interfaces and the developed mobile application will be evaluated with the opinion of experts and pre-application. The effect of the mobile application programme on women's attitudes and behaviours towards cervical cancer prevention and early diagnosis will be evaluated in the 6th and 12th weeks. In the evaluation of the data, t-test, anova and chi-square tests for independent groups will be used to measure the effect of the intervention. Widespread effect; In this way, it is planned to reduce the time spent by professionals for care-related activities, to strengthen time management, to provide advantages and improvements in the performance of nurses in patient care management by using technological resources in the health care provided.
- Conditions
- Cervix Cancer, Cancer Awareness, Mobile Application, HPV, Nurse's Role
- Being tested
- Mobile application
- Medical subject headings
- Uterine Cervical Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mobile applicationBehavioural
The mobile application will be designed as a health assistant for women aged between 30-65 to encourage healthy choices and positively develop their behaviors regarding the prevention of cancer. Within the scope of the mobile application, information modules on cervical cancer screening tests, cervical cancer risk factors, ways to prevent cervical cancer, types of HPV, and HPV vaccine will be provided. A parallel-group pretest-posttest randomized controlled trial design will be used in the second stage of the study
| Study group | Role | What they receive |
|---|---|---|
| Mobile Application Group | Experimental | Within the scope of the mobile application, information modules on cervical cancer screening tests, cervical cancer risk factors, ways to prevent cervical cancer, types of HPV, and HPV vaccine will be provided. A parallel-group pretest-posttest randomized controlled trial design will be used in the second stage of the study. Receives: Behavioral: Mobile application |
| Control Group | No intervention | The relevant brochures of the Ministry of Health on the prevention of cervical cancer will be given to the experimental and control groups. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mobile application development
The effectiveness of the mobile application created for cervical cancer awareness will be evaluated with the Mobile Application Usability Scale-MAUS Scale (Mobile Application Usability Scale-MAUS Scale at Week 12). It has a total of 40 items and 7-point Likert type (1=strongly disagree, 7=completely agree). The range of points that can be obtained from the scale is 42-294. The increase in the score indicates that the usability level of the mobile application is high. There are no items that need to be reverse coded in the scale.
Measured: 3 months
Secondary outcomes (3)
effect of the developed mobile application on cervical cancerearly diagnosis attitudes measured by the Attitude Towards Early Diagnosis of Cervical Cancer Scale
The difference between the attitudes towards early diagnosis of cervical cancer of women who use and do not use the mobile application created for cervical cancer awareness will be compared with the mean scores with the Attitude Towards Early Diagnosis of Cervical Cancer Scale. The scale consists of 30 items and is a Likert-type scale. Of the 30 items in the scale, 22 are positive and 8 are negative statements. The scoring of negative statements is reversed. The highest score to be obtained from the scale is 150 and the lowest score is 30.
Measured: 3 months
effect of the developed mobile application on cervical cancer prevention attitudes measured by the Attitude Scale for Cervical Cancer Prevention
Attitude Scale for Cervical Cancer Prevention: consists of 23 items and three sub-dimensions. The items in the scale using Likert-type. The highest score to be obtained from the scale is 115 and the lowest score is 23. The high score obtained from the scale indicates that the individual has high attitudes towards the prevention of cervical cancer
Measured: 3 months
ffect of the developed mobile application on cervical cancer awareness behaviors measured by the Cervical cancer awareness behaviour questionnaire
Cervical cancer awareness behaviors of women using mobile applications will be measured with- Cervical cancer awareness behaviour questionnaire- an 18-question survey prepared by the researcher in line with the literature. Internal consistency tests for the survey were conducted and the Cronbach alpha value was found to be 0.88-0.98.
Measured: 3 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Feb 2024
- Study start1 Apr 2024
- Primary completion21 Oct 2024
- Study completion27 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cervix CancerStudies of the same condition, open and under way.
- More trials run by Kutahya Health Sciences UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A mobile application developed to increase awareness of cervical cancer among 60 women in the intervention group who met the sample criteria was implemented.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 120 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kutahya Health Sciences University
- Sponsor type
- University, hospital or other
- Collaborators
- Akdeniz University
- Responsible party
- Principal investigator, Fatma Nur Sena, Akdeniz University
- Investigators
- Sena F Karakışla, MSc, Study chair, Akdeniz University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06252012
- Sponsor's protocol ID
- HS-2305
- Status last verified
- Jun 2025
- First submitted
- 4 May 2023
- Last updated
- 3 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Cervical Cancer Awareness Education Based on Mobile Application on Women's Attitudes and Behaviors Regarding Cervical Cancer Prevention and Early Diagnosis
- ClinicalTrials.gov ID
- NCT06252012
- Acronym / sponsor ID
- HS-2305
- Conditions
- Cervix Cancer, Cancer Awareness, Mobile Application, HPV, Nurse's Role
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 120 participants (actual)
- Lead sponsor
- Kutahya Health Sciences UniversityUniversity, hospital or other
- Collaborators
- Akdeniz University
- Study start
- 1 Apr 2024 (actual)
- Primary completion
- 21 Oct 2024 (actual)
- Study completion
- 27 May 2025 (actual)
- First posted
- 9 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cervical cancer is one of the most common cancer types affecting women in our country and in the world and causing morbidity. However, the availability of a vaccine for cervical cancer, preventable risk factors and early diagnosis tests offer a unique opportunity to reduce the rate of cervical cancer. In this context, there are studies showing that the practices developed by policies differ and that the classical health approach is insufficient. The effectiveness of the trainings given may vary according to time, place, trainer and personal characteristics of the individual. At the same time, in order to improve the attitudes and behaviours of individuals in terms of prevention and early diagnosis of cervical cancer, awareness of individuals about cervical cancer should be increased. In this way, women will have a say about their own health and their conscious participation in health care services will be realised. Therefore, the aim of this project is to apply cervical cancer awareness training to women and to examine its effect on women's cervical cancer prevention and early diagnosis behaviours. Original value; The fact that there is no mobile application developed for cervical cancer in Turkey reveals the national value of the research. In addition, the mobile application has international unique value as it is the first mobile application structured to provide awareness on cervical cancer prevention and early diagnosis behaviours. The project method was planned for the development and implementation of the mobile application programme. The research design will be a randomised controlled study. The 120 women who meet the inclusion criteria and who apply to more than one family health centre will be randomly assigned to the intervention and control groups. The effect of the mobile application programme on women's attitudes and behaviours towards cervical cancer prevention and early diagnosis will be evaluated at the 6th and 12th weeks. In the evaluation of the data, t-test for independent groups, anova and chi-square tests will be used to measure the effect of the intervention. Widespread effect; In this way, it is planned to reduce the time spent by professionals for care-related activities, to strengthen time management, to provide advantages and improvements in the performance of nurses in patient care management by using technological resources in the health care provided.
Detailed description
Cervical cancer is one of the most common cancer types affecting women in our country and in the world and causing morbidity. However, the availability of a vaccine for cervical cancer, preventable risk factors and early diagnosis tests offer a unique opportunity to reduce the rate of cervical cancer. The World Health Organization launched the "global strategy to accelerate the elimination of cervical cancer as a public health problem" programme in 2020 to eliminate cervical cancer by 2030. In this context, there are studies showing that the practices developed by policies differ and that the classical health approach is insufficient. The effectiveness of the trainings given may vary according to time, place, trainer and personal characteristics of the individual. At the same time, in order to improve the attitudes and behaviours of individuals in terms of prevention and early diagnosis of cervical cancer, awareness of individuals about cervical cancer should be increased. In this way, women will have a say about their own health and their conscious participation in health care services will be realised. Therefore, the aim of this project is to apply cervical cancer awareness training to women and to examine its effect on women's cervical cancer prevention and early diagnosis behaviours. Original value; the fact that there is no mobile application developed for cervical cancer in our country reveals the national value of the research. In addition, the mobile application has an international unique value as it is the first mobile application structured to provide awareness about cervical cancer prevention and early diagnosis behaviours. It is thought that the mobile application programme to be developed has a unique content that provides knowledge and skills to increase the health culture and participation in health decisions thanks to its educational content such as cervical cancer risk factors, prevention methods, diagnostic tests, test results, treatment methods. In addition, it is the first mobile application developed in the national/international field regarding cervical cancer prevention and early diagnosis attitudes and behaviours in line with the deficiencies identified in the literature. The project method was planned for the development and implementation of the mobile application programme. The research design will be a randomised controlled study. A total of 120 women who meet the inclusion criteria and apply to more than one family health centre will be randomly assigned to the intervention (women who use the mobile application programme) and control groups (women who receive the standard education booklet). The mobile application programme includes a total of 12 interfaces for cervical cancer prevention and early diagnosis of cervical cancer. The content of the interfaces and the developed mobile application will be evaluated with the opinion of experts and pre-application. The effect of the mobile application programme on women's attitudes and behaviours towards cervical cancer prevention and early diagnosis will be evaluated in the 6th and 12th weeks. In the evaluation of the data, t-test, anova and chi-square tests for independent groups will be used to measure the effect of the intervention. Widespread effect; In this way, it is planned to reduce the time spent by professionals for care-related activities, to strengthen time management, to provide advantages and improvements in the performance of nurses in patient care management by using technological resources in the health care provided.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
- Model description
- A mobile application developed to increase awareness of cervical cancer among 60 women in the intervention group who met the sample criteria was implemented.
| Arm | Type | Receives |
|---|---|---|
| Mobile Application Group | Experimental | Behavioral: Mobile applicationWithin the scope of the mobile application, information modules on cervical cancer screening tests, cervical cancer risk factors, ways to prevent cervical cancer, types of HPV, and HPV vaccine will be provided. A parallel-group pretest-posttest randomized controlled trial design will be used in the second stage of the study. |
| Control Group | No intervention | –The relevant brochures of the Ministry of Health on the prevention of cervical cancer will be given to the experimental and control groups. |
Who may qualify
- Ages
- 35 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- She applied to Yıldırım Beyazıt Family Health Center and Zafertepe Family Health Center in Kütahya.
Key exclusion criteria (1 listed)
- Pregnancy women Breastfeeding Have a history of cancer Have undergone hysterectomy operation Those who have undergone an operation for cervical cancer (cryosurgery, etc.)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mobile applicationThe mobile application will be designed as a health assistant for women aged between 30-65 to encourage healthy choices and positively develop their behaviors regarding the prevention of cancer. Within the scope of the mobile application, information modules on cervical cancer screening tests, cervical cancer risk factors, ways to prevent cervical cancer, types of HPV, and HPV vaccine will be provided. A parallel-group pretest-posttest randomized controlled trial design will be used in the second stage of the study | Behavioural | Mobile Application Group |
Primary outcome
Mobile application development
Time frame: 3 months
The effectiveness of the mobile application created for cervical cancer awareness will be evaluated with the Mobile Application Usability Scale-MAUS Scale (Mobile Application Usability Scale-MAUS Scale at Week 12). It has a total of 40 items and 7-point Likert type (1=strongly disagree, 7=completely agree). The range of points that can be obtained from the scale is 42-294. The increase in the score indicates that the usability level of the mobile application is high. There are no items that need to be reverse coded in the scale.
3 secondary outcomes
effect of the developed mobile application on cervical cancerearly diagnosis attitudes measured by the Attitude Towards Early Diagnosis of Cervical Cancer Scale
Time frame: 3 months
effect of the developed mobile application on cervical cancer prevention attitudes measured by the Attitude Scale for Cervical Cancer Prevention
Time frame: 3 months
ffect of the developed mobile application on cervical cancer awareness behaviors measured by the Cervical cancer awareness behaviour questionnaire
Time frame: 3 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Cervix Cancer
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
RecruitingPhase 3
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
RecruitingPhase 2
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma
Enrolling by invitationObservational study
Use of cfDNA in Monitoring and Guiding Treatment for Cervical Cancer
Cervical Cancer Screening
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Sena F Karakışla, MSc study chair
Akdeniz University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mobile application in people with Cervix Cancer and Cancer Awareness, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mobile application development (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2025.